Patents by Inventor Yona Grunfeld

Yona Grunfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5106831
    Abstract: A pharmaceutical composition is disclosed comprising (-)-cis-2-methylspiro(1,3-oxathiolan-5,3')quinuclidine, and/or the pharmaceutically compatible acid addition salts thereof, together with at least one of physostigmine, tetrahydroaminoacridine, choline, lecithin, piracetam, aniracetam, pramiracetam, oxiracetam, 4-aminopyridine, 3,4-diaminopyridine, somatostatin, pirenzepine, N-methylatropine, N-butylscopolamine, scopolamine, clonidine, quanfamicine and Nerve Growth Factor. Also disclosed is a method for treating senile dementia of Alzheimer's type, which comprises coadministering to a patient in need thereof an effective dose of the spiro compound together with at least one other compound selected from those listed above.
    Type: Grant
    Filed: October 19, 1990
    Date of Patent: April 21, 1992
    Assignee: State of Israel, represented by the Prime Minister's office, Israel Institute for Biological Research
    Inventors: Abraham Fisher, Ishai Karton, Eliahu Heldman, Yona Grunfeld, Aharon Levy
  • Patent number: 4981858
    Abstract: The (+)-cis-, (-)-cis-, (+)-trans- and (-)-trans- forms of 2-methylspiro(1,3-oxathiolan-5,3')quinuclidine are prepared by optical resolution of each of the (.+-.)-cis- and (.+-.)-trans-isomers. These compounds find application in treating diseases of the central nervous system in mammals, especially diseases due to a deficiency in the central cholinergic system. Biological tests indicate that the (-)-cis-form, as well as the (.+-.)-cis-isomer, shows particular promise for treating senile dementia of Alzheimer's type.
    Type: Grant
    Filed: April 18, 1989
    Date of Patent: January 1, 1991
    Assignee: State of Israel, represented by the Prime Minister's Office, Israel Institute for Biological Research
    Inventors: Abraham Fisher, Ishal Karton, Eliahu Heidman, Yona Grunfeld, Aharon Levy
  • Patent number: 4855290
    Abstract: Quinuclidine derivatives having the general formula (I) ##STR1## and geometrical isomers, enantiomers, diastereoisomers, racemates and/or acid addition salts thereof, wherein Z represents the group >CR.sup.1 R.sup.2 or two hydrogen atoms; and R.sup.1 and R.sup.2, which may be identical or different, are each alkyl, cyclopentyl, cyclohexyl, aryl, or diarylmethylol, or alkyl which is substituted by one or more aryl groups, or one of R.sup.1 and R.sup.2 may be hydrogen.
    Type: Grant
    Filed: April 18, 1986
    Date of Patent: August 8, 1989
    Assignee: State of Israel, represented by Prime Minister's Office, Israel Institute for Biological Research
    Inventors: Abraham Fisher, Ishai Karton, Eliahu Heldman, Aharon Levy, Yona Grunfeld
  • Patent number: 4112082
    Abstract: Organo-phosphorus compounds of the general formula ##STR1## wherein Z is a member selected from ##STR2## wherein R and R' are each selected from hydrogen and lower alkyl, R" designates a member selected from methyl and ethyl, and X.sup.- is an anion may be used as active ingredient in pharmaceutical and pesticidal, especially acaricidal and fungicidal, compositions of matter of low mammalian toxicity.
    Type: Grant
    Filed: October 30, 1975
    Date of Patent: September 5, 1978
    Assignee: The State of Israel, Prime Minister's Office, The Israel Institute for Biological Research
    Inventors: Yacov Ashani, Gavriel Amitai, Yona Grunfeld, Asher Kalir, Sasson Cohen